The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. 

Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 2,500 people worldwide, and we market our products in more than 50 countries. We have 13 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines.

Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.

Pharmaceutical

Julphar

Basel Ziyadeh

Muhammed S.

Muhamed Asfour

Mohamed Nabil

Hayyan Tahir

Sameh Mohamed Ali Farag

Mohamed Awad

Hisham Salem

Kashif Kamal

Gargi Banerjee Sphri® Gphr®

Shehdeh A.

Mohamed Halboni

Alaa Fathi Atia Mbbch

G Kumar

Jürgen Lauterbach

The Financial and Business Analysis Team at Julphar is responsible for overseeing financial planning, consolidating accounting activities, and providing strategic financial insights to support business decisions. This team manages the ERP systems, analyses financial data, and partners with commercial teams to enhance business performance and ensure financial compliance and efficiency within the organization.

Financial and Business Analysis Team

Human Resources

Information Technology

Global Portfolio Management Team

Financial and Business Analysis Team

About

Team members

Other teams at Julphar

Human Resources

Information Technology

Global Portfolio Management Team